Results 171 to 180 of about 14,427,656 (303)

Hepatitis B virus infection with high HBsAg and undetectable DNA levels in untreated blood donors: Viral mechanisms and transfusion safety implications

Transfusion, EarlyView.
Abstract Background Blood donor screening occasionally identifies individuals with high HBV surface antigen (HBsAg) levels despite undetectable or extremely low HBV DNA. Molecular basis and transfusion risk of this discordant profile remain unclear. Study Design and Methods Seventy‐five blood donors with HBsAg >100 IU/mL and undetectable or very low ...
Maelenn Païline Delcourt, Marion Vermeulen, Aneta Kopacz, Manuela Miletic, Andrew Saville, Christoph Niederhauser, Jean‐Michel Pawlotsky, Syria Laperche, Daniel Candotti   +8 more
wiley   +1 more source

Progress and challenge of hepatitis B virus mucosal vaccines. [PDF]

Virol J
Renxuan J, Hongxiang L, Daru L.
europepmc   +1 more source

A preS2 aa1-26-specific humoural response marks functional cure in chronic HBV infection. [PDF]

EBioMedicine
Wang YY, Fu JL, Wang WX, Wang HM, Liu SQ, Sun Y, Wang ZW, Li J, Zhou MJ, Li WZ, Zhu MM, Li X, Yang YX, Chen SY, Yang T, Fan X, Xu RN, Jiao YM, Song JW, Zhen C, Zhang M, Shi M, Wang FS, Zhang C.   +23 more
europepmc   +1 more source

Mucosal‐Associated Invariant T Cells in Health and Disease

MedComm, Volume 7, Issue 10, October 2026.
The roles of MAIT cells in health and disease and their therapeutic applications. In healthy individuals, riboflavin metabolites secreted by commensal bacteria at mucosal sites are presented by MR1, leading to the activation of MAIT cells. Activated MAIT cells can maintain the barrier integrity of mucosal tissues in a steady state or migrate to the ...
Yu Zhao, Feng‐Mi Ou, Dan Liang, Yang Gao, Qing‐Qing Li, Yi‐Qun Kuang   +5 more
wiley   +1 more source

Differential Hepatitis B Surface Antigen Glycan Isomer Kinetics Between Tenofovir Alafenamide and Entecavir: Hepatocellular Carcinoma Risk Stratification in Hepatitis B e Antigen-Positive Patients. [PDF]

J Viral Hepat
Kita Y, Murata A, Nago H, Yamaguchi M, Kato Y, Om R, Terai Y, Ikeda Y, Sato S, Sato S, Shimada Y, Genda T.   +11 more
europepmc   +1 more source

Evasins: Biology and Therapeutic Potential of Broad‐Spectrum Chemokine Inhibitors

Basic &Clinical Pharmacology &Toxicology, Volume 139, Issue 4, October 2026.
ABSTRACT Ticks are haematophagous parasites that rely on uninterrupted bloodmeals for survival and need an effective strategy to suppress the host inflammatory response. Leukocyte recruitment is a chemokine‐mediated hallmark of inflammation, which ticks counteract via anti‐chemokine proteins in their saliva named evasins.
Emilia L. Bialek, Roos Buds, Ingrid Dijkgraaf, Pedro E. Marques   +3 more
wiley   +1 more source

Hepatitis C virus-associated B-cell non-Hodgkin lymphomas: immune evasion, multistep lymphomagenesis, and candidate biomarkers for risk stratification and disease monitoring. [PDF]

Front Immunol
Carloni G, Ponzetto A, Rinaldi M.
europepmc   +1 more source

Progress Towards Eliminating Hepatitis C as a Public Health Threat in Norway

Journal of Viral Hepatitis, Volume 33, Issue 10, October 2026.
ABSTRACT The World Health Organisation aims to eliminate hepatitis C virus (HCV) infection as a public health threat by 2030. We assessed progress towards HCV elimination in Norway until the end of 2024. We used linked national registry data to describe diagnosed cases of HCV infection by treatment uptake and case characteristics, and the incidence of ...
Robert Whittaker, Linda Couëssurel Wüsthoff, Jørgen Eriksson Midtbø, Håvard Midgard, Olav Dalgard   +4 more
wiley   +1 more source

Two Diagnostic Challenges in Hepatitis B Serology: Low HBsAg S/CO Values and Isolated Anti-HBc Positivity. [PDF]

Pathogens
Yılmaz Gürbüz Ş, Yağdı O, Başar E.   +2 more
europepmc   +1 more source

Hepatitis B : are you at risk? [Hmong]

Hepatitis B : are you at risk? [Hmong]Hmong Publication No. 221613These sheets have the English translation on the back.cdc/gov/knowhepatitisBFactSheet-HepBAreYouAtRisk_hmg ...

core